Noor Ul Ain Rehman
Mon, February 23, 2026 astatine 9:57 AM CST 2 min read
Zoetis Inc. (NYSE:ZTS) further reported $9.5 cardinal successful gross for the afloat twelvemonth 2025, reflecting a maturation of 2% compared to afloat twelvemonth 2024. On an integrated operational basis, gross for the afloat twelvemonth 2025 roseate 6%, and nett income for the twelvemonth was $2.7 billion, oregon $6.02 per diluted share, an summation of 8% and 10%, respectively, connected a reported basis.
Zoetis Inc. (NYSE:ZTS) is simply a planetary carnal wellness institution that focuses connected the discovery, development, manufacture, and commercialization of vaccines, medicines, biodevices, familial tests, diagnostic products, and precision carnal health. Its operations are divided into the United States and International segments, with each conception boasting a diversified merchandise portfolio, including vaccines, parasiticides, symptom and sedation, carnal wellness diagnostics, and more. The institution specializes successful products crossed 8 halfway species: companion animals (dogs, cats, and horses), cattle, swine, livestock (sheep and fish), and poultry.
While we admit the imaginable of ZTS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This nonfiction is primitively published at Insider Monkey.

1 month ago
25



.png)

English (CA) ·
English (US) ·
Spanish (MX) ·